APA (7th ed.) Citation

Kim, B., Choi, E. Y., Kim, C. Y., Song, K., & Joo, Y. H. (2008). Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting. Human Psychopharmacology: Clinical & Experimental, 23(1), 61. https://doi.org/10.1002/hup.897

Chicago Style (17th ed.) Citation

Kim, Byngsu, Eui Yul Choi, Chang Yoon Kim, Kyuyung Song, and Yeon Ho Joo. "Could HTR2A T102C and DRD3 Ser9Gly Predict Clinical Improvement in Patients with Acutely Exacerbated Schizophrenia? Results from Treatment Responses to Risperidone in a Naturalistic Setting." Human Psychopharmacology: Clinical & Experimental 23, no. 1 (2008): 61. https://doi.org/10.1002/hup.897.

MLA (9th ed.) Citation

Kim, Byngsu, et al. "Could HTR2A T102C and DRD3 Ser9Gly Predict Clinical Improvement in Patients with Acutely Exacerbated Schizophrenia? Results from Treatment Responses to Risperidone in a Naturalistic Setting." Human Psychopharmacology: Clinical & Experimental, vol. 23, no. 1, 2008, p. 61, https://doi.org/10.1002/hup.897.